Pimecrolimus Cream 1% for the Treatment of Papulopustular Eruption Related to Epidermal Growth Factor Receptor Inhibitors: A Case Series and a Literature Review of Therapeutic Approaches | Zendy

Vasiliki Nikolaou | Zendy; Alexander Stratigos | Zendy; C. Antoniou | Zendy; M. Kiagia | Zendy; Charalampos Nikolaou | Zendy; Andreas Katsambas | Zendy; K. Syrigos | Zendy

Open Access

Pimecrolimus Cream 1% for the Treatment of Papulopustular Eruption Related to Epidermal Growth Factor Receptor Inhibitors: A Case Series and a Literature Review of Therapeutic Approaches

Author(s) -

Vasiliki Nikolaou,

Alexander Stratigos,

C. Antoniou,

M. Kiagia,

Charalampos Nikolaou,

Andreas Katsambas,

K. Syrigos

Publication year - 2010

Publication title -

dermatology

Language(s) - English

Resource type - Journals

eISSN - 1421-9832

pISSN - 1018-8665

DOI - 10.1159/000277430

Subject(s) - papulopustular , pimecrolimus , medicine , dermatology , erythema , drug eruption , surgery , pharmacology , calcineurin , rosacea , drug , transplantation , acne

Cutaneous side effects of epidermal growth factor receptor inhibitors (EGFRIs) are very frequent and well known. The aim of our study was to investigate the efficacy and safety of pimecrolimus 1% cream in the treatment of papulopustular eruption caused by EGFRIs and to review the relevant literature on therapeutic approaches.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research